Conformis Maintains Commitment to Advancing Patient-Specific Solutions by Expanding Scientific Advisory Board
New Additions Enhance World Class Expertise in Total and Partial Knee Systems
Burlington, Mass. — February 23, 2009 – Conformis, Inc., a medical device company that develops and commercializes patient-specific solutions for the treatment of osteoarthritis and joint damage, announced today the addition of three new members to the Scientific Advisory Board: Amar S. Ranawat, MD; Anil S. Ranawat, MD, and Brian McKeon, MD. The board is comprised of a group of internationally recognized orthopedic surgeons and scientists who facilitate the company’s ongoing efforts to develop and deliver patient-specific solutions. Most recently, Conformis announced the appointment of Dr. Richard Scott, an expert in partial and total knee replacement, to their Scientific Advisory Board.
“Drs. Amar Ranawat and Anil Ranawat add invaluable perspective to our iTotal™ Tricompartmental Knee Resurfacing program, with their combined experience in primary and revision total knee replacements as well as joint preserving surgical techniques,” said Philipp Lang, MD, CEO of Conformis. “In addition, Dr. Brian McKeon’s clinical research program with our partial knee resurfacing system brings world-class perspective from the sports medicine community to Conformis. We believe the appointment of these surgeons to our Board will help Conformis continue developing innovative, clinically relevant applications for our patient-specific technologies.”
Amar S. Ranawat, MD is an Assistant Professor of Orthopaedic Surgery at Weill Cornell Medical College and currently practices at Hospital for Special Surgery in New York City. Dr. Ranawat earned his medical degree from Weill Medical College of Cornell University and completed his fellowship training in Adult Reconstruction under the direction of his father Dr. Chitranjan S. Ranawat. Dr. Ranawat has received numerous academic and professional accolades, including the Chief Resident’s Special Award, the Navy and Marine Corps Achievement Medal, the Hip Society British Traveling Fellowship, and the James A. Rand Award. He is an active clinical orthopedic researcher with particular interests in alternative bearing surfaces for total hip replacement and innovative total knee designs.
Anil S. Ranawat, MD is an Instructor in Orthopaedic Surgery at Weill Cornell Medical College and currently practices at Hospital for Special Surgery. Dr. Ranawat earned his medical degree from Weill Medical College of Cornell University, completed an Orthopaedic Surgery residency at HSS, a Sports Medicine Fellowship at University of Pittsburgh Medical Center, and a Joint Preservation Hip Fellowship at the Schulthess Klinic in Zurich, Switzerland. Dr. Ranawat has received numerous awards including the T. Campbell Thompson Award for Excellence in Orthopedic Surgery, the Jean C. McDaniel Resident Teaching Award at Hospital for Special Surgery, the Maurice Müller European Traveling Hip Fellowship and the AAOS Washington Health Policy Fellowship. His clinical and research interests are focused on joint-preservation surgery of the knee and hip, with a deep interest in robotic surgery, partial knee replacement and mobile-bearing technology.
Brian P. McKeon, M.D. is an Assistant Clinical Professor of Orthopedics at Tufts University School of Medicine and a Sports Medicine Fellowship Instructor at New England Baptist Hospital in Boston, MA where he currently practices. In addition, Dr. McKeon is the Chief Medical Officer and Team Physician for the current World Champion Boston Celtics. Dr. McKeon earned his medical degree with honors from Georgetown University’s School of Medicine. Following his residency and internship training with the University of Connecticut’s Integrated Residency Program, he completed a Sports Medicine Fellowship at New England’s Baptist Hospital in Boston. He is currently participating in several clinical trials and funded research studies related to articular cartilage, sports injuries, and partial knee replacement.
About Conformis, Inc.
Conformis, Inc. is a privately held company incorporated in 2004 that develops and commercializes medical devices for the treatment of osteoarthritis and joint damages. The Company’s novel and scaleable ‘image-to-implant’ process is comprised of two related technology platforms. iFit™ Technology enables the creation of conforming, patient-specific implants that are precisely sized and shaped to match the 3D topography of the patient’s anatomic bone surfaces. The iJig™ Instrumentation enables the creation of novel disposable instrumentation that radically simplifies and improves the surgical process.
Both platforms are supported by proprietary, intellectual property consisting of more than 250 issued, allowed and pending patents or patent applications that span imaging software, image processing, implant design, surgical techniques and instrumentation.
To date, Conformis has developed a comprehensive line of minimally traumatic, bone and cartilage-preserving knee implants and instrumentation designed to address all stages of osteoarthritis, the most common reason for knee replacement surgery. Each of these devices has been cleared by the US Food and Drug Administration for marketing in the U.S.
Conformis and Stryker Execute Development, License and Distribution Agreements
Deal to Cover Patient-Specific Instrumentation Used in Knee Arthroplasty BILLERICA, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ: CFMS), a medical technology
New Peer Reviewed Data Supports Use of Conformis Customized Knee Implants to Match Anatomic Variability in Patients
BILLERICA, Mass., April 23, 2019 (GLOBE NEWSWIRE) — Conformis Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit